cladribine has been researched along with Peripheral Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agazzi, A; Andreola, G; Bassi, S; Bertazzoni, P; Gigli, F; Laszlo, D; Martinelli, G | 1 |
| Foley, KM; Rosenblum, M; Vahdat, L; Warrell, RP; Wile, MJ; Wong, ET | 1 |
| Fronczak, A; Góra-Tybor, J; Krykowksi, E; Robak, T; Warzocha, K | 1 |
1 trial(s) available for cladribine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Axons; Cladribine; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Middle Aged; Motor Neurons; Neural Conduction; Peripheral Nervous System Diseases; Sural Nerve | 1994 |
2 other study(ies) available for cladribine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Severe neuropathy in a patient with Waldenstrom disease: from a challenging diagnosis to clinical improvement by innovative therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Rituximab; Waldenstrom Macroglobulinemia | 2006 |
Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma.
Topics: Adult; Antineoplastic Agents; Cladribine; Humans; Lymphoma, Non-Hodgkin; Male; Paraneoplastic Syndromes; Peripheral Nervous System Diseases | 1996 |